Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients-Reference-Cited by-同舟云学术

Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients

Published:2016-12-26 Issue:5 Volume:29 Page:299-307
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Gagliardini Roberta¹,Fabbiani Massimiliano²,Colafigli Manuela³,D’Avino Alessandro¹,Mondi Annalisa¹,Borghetti Alberto¹,Lamonica Silvia¹,Cauda Roberto¹^ORCID,De Luca Andrea¹⁴,Di Giambenedetto Simona¹

Affiliation:

1. Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy

2. Division of Infectious Diseases, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy

3. Infectious Dermatology and Allergology Unit, IFO S. Gallicano Institute (IRCCS), Rome, Italy

4. Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2016.1269040

Reference29 articles.

1. Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

2. Mortality in the Highly Active Antiretroviral Therapy Era

4. Metabolic Consequences of HIV: Pathogenic Insights

5. Osteoporosis and Bone Health in HIV

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B;Journal of Medical Virology;2024-06-28

2. Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV;BMC Infectious Diseases;2021-09-06

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

;Drug Design, Development and Therapy;2020-12

4. Cardiovascular Risk Assessment in People Living With HIV: A Systematic Review and Meta-Analysis of Real-Life Data;Current HIV Research;2020-02-17

5. Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back;AIDS;2019-12-01